CRIS earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.21. Updated 2026-07-23.
Curis (CRIS) Research Hub
Curis (CRIS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.13 USD (-5.83%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.21, market cap 0.01B. This hub links to the full technical, earnings and options research available for CRIS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.13 USD (-5.83%) |
| 52-week range | 1.13 USD – 11.4 USD |
| Trend regime | Range |
| 14-day RSI | 0.3 (Oversold) |
| Trailing P/E | -0.21 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for CRIS
Covered Call on CRIS: how it works, illustrative setup around the real 1.13 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CRIS: how it works, illustrative setup around the real 1.13 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CRIS: how it works, illustrative setup around the real 1.13 USD price, max profit/loss, breakeven and when to use it. Educational.
CRIS technical analysis: range, last 1.13 USD, RSI 0.3, 52w range 1.13 USD–11.4 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CRIS in?
Curis (CRIS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CRIS in an uptrend or downtrend?
As of 2026-09-11, CRIS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CRIS's trailing P/E ratio?
CRIS's trailing P/E is -0.21, with a market cap of 0.01B. See the earnings research page for full valuation detail.